| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 128.422.031 $ | +10.205.603 $ | +25,7 % | 12 | 139.492.635 $ | +139.492.635 $ | 13 | |||||
| Kyverna Therapeutics, Inc. | KYTX | → 0 | Schwach | 36.632.779 $ | -4.650.310 $ | -11,3 % | 1 | 41.283.089 $ | +41.283.089 $ | 1 | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | → 0 | Neutral | 5.621.003 $ | -18.396.653 $ | -76,6 % | 1 | 24.017.656 $ | +24.017.656 $ | 1 | |
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Schwach | 22.215.006 $ | +14.895.050 $ | +203,5 % | 1 | 7.319.956 $ | +7.319.956 $ | 1 | |
| Vir Biotechnology, Inc. | VIR | → 0 | Schwach | 13.606.226 $ | +7.996.414 $ | +142,5 % | 1 | 5.609.812 $ | +5.609.812 $ | 1 | |
| Bausch & Lomb Corp | BLCO | → 0 | Neutral | 9.118.205 $ | -1.359.897 $ | -13,0 % | 1 | 10.478.102 $ | +10.478.102 $ | 1 | |
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | Neutral | 10.433.484 $ | +10.433.484 $ | 1 | |||||
| AMGEN INC | AMGN | → 0 | Stark | 7.111.592 $ | -485.928 $ | -6,4 % | 1 | 7.597.520 $ | +7.597.520 $ | 1 | |
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 6.056.666 $ | -1.512.657 $ | -20,0 % | 1 | 7.569.323 $ | +7.569.323 $ | 1 | |
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 6.513.700 $ | +6.513.700 $ | 1 | |||||
| Pyxis Oncology, Inc. | PYXS | → 0 | Schwach | 6.017.930 $ | +1.277.779 $ | +27,0 % | 1 | 4.740.151 $ | +4.740.151 $ | 1 | |
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 5.459.758 $ | +5.459.758 $ | 1 | |||||
| Sionna Therapeutics, Inc. | SION | → 0 | Schwach | 5.452.240 $ | +5.452.240 $ | 1 | |||||
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 5.402.138 $ | +776.600 $ | +16,8 % | 1 | 4.625.538 $ | +4.625.538 $ | 1 | |
| INCYTE CORP | INCY | → 0 | Stark | 5.382.965 $ | +5.382.965 $ | 1 | |||||
| INSMED Inc | INSM | → 0 | Neutral | 4.674.546 $ | -300.735 $ | -6,0 % | 1 | 4.975.281 $ | +4.975.281 $ | 1 | |
| 128.422.031 $ | +10.205.603 $ | +25,7 % | 12 | 139.492.635 $ | +139.492.635 $ | 13 | |||||